Listing Compliance Department
As filed · Bal Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on November 11, 2026.As intimated vide our letter dated November 03, 2026, Board of directors of the Company met on
CapitalNotablemateriality 73 out of 100
What happened
FactListing Compliance Department.
Why it matters
CapitSignal interpretationShares are issued to named investors at a set price, diluting existing holders and changing who sits on the register.
Watch next
Fact- Who the allottees are
- Issue price versus market price
- Lock-in period on the new shares
Evidence
How CapitSignal classified this
- Reasoning:
- PREFERENTIAL_ALLOTMENT base 66; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%